Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene Polymorphism.

CONCLUSIONS: Determining the BDNF protein levels before initiating chemotherapy might be a useful tool for CIPN risk assessment and preemptive dose modification. The present data should be validated in larger studies that include other neurotoxic agents. PMID: 31591840 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31591840?dopt=Abstract

Source: Journal of Clinical Neurology - October 9, 2019 Category: Neurology Tags: J Clin Neurol Source Type: research